Sleep apnea has a statistics problem. Not a shortage of them — quite the opposite. Numbers circulate widely in patient materials, advocacy content, media coverage, and clinical literature, and they are not all equally reliable. Some are drawn from rigorous population studies with large representative samples. Others are extrapolations from small clinical cohorts, figures that have been updated by better research but continue to circulate, or numbers that are technically accurate but presented without the context that makes them meaningful.
For patients and providers who want to understand what the evidence actually supports, working through the sleep apnea facts and statistics with some critical attention to methodology produces a more honest picture than accepting all figures at face value.
Prevalence — What the Good Studies Show
The most frequently cited prevalence figure for sleep apnea in the United States is that approximately 22 million Americans have the condition, though more recent analyses based on larger and more methodologically rigorous population studies have revised this upward to estimates in the range of 30 million or more. The discrepancy reflects both genuine increases in prevalence driven by rising obesity rates and improved epidemiological methods that capture more of the population.
Global figures of 900 million or more affected adults come from a 2019 analysis published in The Lancet Respiratory Medicine, based on data from 16 countries using standardized diagnostic criteria. This is among the more methodologically credible large-scale prevalence estimates available, though it relies on modeling rather than direct measurement in all populations, and confidence intervals are wide.
What is well established is that sleep apnea is highly prevalent across all studied populations, that prevalence increases with age and body weight, and that men are affected at higher rates than women. The specific numbers attached to these patterns vary by study, diagnostic threshold used, and population studied — which is why a range rather than a single figure is a more honest representation of what the data supports.
The Underdiagnosis Statistic — Reliable in Direction, Uncertain in Magnitude
The claim that 80% or more of sleep apnea cases are undiagnosed is widely cited and directionally accurate — undiagnosis is genuinely the dominant feature of sleep apnea epidemiology. The specific percentage, however, is harder to pin down with precision because it requires both an estimate of true prevalence and an estimate of diagnosed cases, each of which carries its own uncertainty.
What can be said with confidence is that the number of people in the United States receiving treatment for sleep apnea is substantially smaller than the number epidemiological studies suggest are affected. The direction of the finding — massive underdiagnosis — is robust. The specific fraction, whether 80% or 85% or 90%, is less certain and should be understood as an approximate illustration of the gap rather than a precisely measured figure.
Cardiovascular Statistics — Strong Associations, Causation More Nuanced
The cardiovascular statistics associated with sleep apnea are among the most frequently cited — and among those most in need of careful interpretation. The association between sleep apnea and hypertension, stroke, atrial fibrillation, and cardiovascular mortality is well established across multiple large observational studies. These associations are real and clinically meaningful.
What is sometimes overstated is the degree to which these associations represent independent causal relationships versus shared risk factor clustering. Sleep apnea, obesity, hypertension, diabetes, and cardiovascular disease share overlapping risk factors, and separating the independent contribution of sleep apnea to cardiovascular outcomes — after controlling for obesity and other confounders — is methodologically challenging. Most studies do control for major confounders, and sleep apnea retains independent statistical associations with cardiovascular outcomes after adjustment, but the strength of those associations is generally more modest after full adjustment than the unadjusted figures suggest.
The mortality statistics — claims that severe untreated sleep apnea doubles or triples cardiovascular mortality risk — come primarily from observational cohort studies with follow-up periods of several years to decades. These studies have important methodological strengths but also limitations including survival bias, variable control for confounders, and differences in how sleep apnea severity was measured across study populations. The direction of the finding is consistent and credible; the specific magnitude should be understood as an estimate with meaningful uncertainty rather than a precise figure.
The CPAP Adherence Numbers — Frequently Cited, Context Dependent
Claims that half of CPAP patients stop using their devices within the first year are common in both clinical and patient-facing literature, and they reflect a genuine adherence challenge. However, adherence statistics vary considerably depending on how adherence is defined, how it is measured, the patient population studied, the support provided, and the time period examined.
Studies using objective data from device modems — the most accurate measurement method — tend to show better adherence than older studies relying on patient self-report, which is systematically biased toward overreporting. Studies conducted in clinical settings with structured follow-up support show better adherence than those examining patients with minimal post-prescription support. The headline figure of roughly 50% long-term adherence is a reasonable central estimate, but it encompasses a wide range of real-world outcomes depending on these variables.
The Accident Risk Statistics — Striking but Worth Contextualizing
The figures commonly cited for motor vehicle accident risk in sleep apnea patients — estimates of two to seven times higher risk compared to the general population — are drawn from a range of studies using different methodologies, different definitions of sleep apnea severity, and different accident outcome measures. The range itself signals the variability in the underlying evidence.
What is consistent across studies is a meaningful elevation in accident risk associated with untreated sleep apnea and excessive daytime sleepiness. The upper end of the cited range — seven times higher risk — comes from studies in specific high-severity populations and should not be generalized to all sleep apnea patients. A more conservative estimate of two to three times elevated risk for moderate to severe untreated disease is better supported across the body of evidence as a whole.
Reading the Numbers Honestly
None of the caveats above change the fundamental conclusion that sleep apnea is highly prevalent, substantially underdiagnosed, and associated with serious health consequences that are meaningfully reduced by effective treatment. The evidence base supporting these conclusions is large and consistent across decades of research in multiple countries.
What critical reading of the statistics does is prevent individual figures from being used with more precision than the underlying evidence supports — a discipline that serves both patients trying to understand their own situation and providers trying to counsel them accurately. The honest picture is compelling enough without overstating what any single number can reliably claim.